1. Home
  2. LPSN vs CCEL Comparison

LPSN vs CCEL Comparison

Compare LPSN & CCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo LivePerson Inc.

LPSN

LivePerson Inc.

HOLD

Current Price

$1.95

Market Cap

32.3M

Sector

Technology

ML Signal

HOLD

Logo Cryo-Cell International Inc.

CCEL

Cryo-Cell International Inc.

N/A

Current Price

$2.90

Market Cap

30.9M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
LPSN
CCEL
Founded
1995
1989
Country
United States
United States
Employees
N/A
76
Industry
EDP Services
Managed Health Care
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
32.3M
30.9M
IPO Year
2000
2022

Fundamental Metrics

Financial Performance
Metric
LPSN
CCEL
Price
$1.95
$2.90
Analyst Decision
Hold
Hold
Analyst Count
1
1
Target Price
N/A
N/A
AVG Volume (30 Days)
87.9K
3.2K
Earning Date
05-06-2026
04-14-2026
Dividend Yield
N/A
4.26%
EPS Growth
N/A
N/A
EPS
N/A
0.01
Revenue
$249,838,000.00
$25,384,279.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$384.00
Revenue Growth
N/A
9.76
52 Week Low
$0.39
$2.72
52 Week High
$7.54
$5.43

Technical Indicators

Market Signals
Indicator
LPSN
CCEL
Relative Strength Index (RSI) 38.27 42.84
Support Level $0.39 $3.02
Resistance Level $2.44 $3.92
Average True Range (ATR) 0.11 0.20
MACD -0.01 -0.00
Stochastic Oscillator 30.14 21.51

Price Performance

Historical Comparison
LPSN
CCEL

About LPSN LivePerson Inc.

LivePerson Inc is the enterprise leader in digital customer conversation. The Conversational Cloud, the Companies enterprise-class digital customer conversation platform, is trusted by the brands to accelerate their contact center transformation, orchestrate conversations across all channels, departments, and systems, increase agent productivity, and deliver more personalized, AI-empowered customer experiences. The company has a presence in the United States, Asia-Pacific, Latin America, and Europe.

About CCEL Cryo-Cell International Inc.

Cryo-Cell International Inc is engaged in cellular processing and cryogenic storage. The company is organized into three reportable segments namely cellular processing and cryogenic storage, with a focus on the collection and preservation of umbilical cord blood and tissue stem cells for family use and the manufacturing of PrepaCyte CB units segment, which is a processing technology used to process umbilical cord blood stem cells. The cellular processing and cryogenic storage of umbilical cord blood stem cells for public use. The company generates maximum revenue from Cellular processing and Cryogenic storage and it derives revenue from processing and testing fees and Storage segment.

Share on Social Networks: